Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02051101 · ClinicalTrials.gov registry record · NA
Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02051101 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 19 participants.
The verdict
NCT02051101, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the pathogenic mechanisms of Port Wine Stain, collect biopsy samples and blood samples to characterize exosomes and metabolites from Port Wine Stain.
Interventions
- OTHER Biopsy sample from Port Wine Stain Birthmark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2013-04-23 |
| Est. Completion | 2019-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02051101
The ClinicalTrials.gov registry entry for NCT02051101 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biopsy sample from Port Wine Stain Birthmark is the first listed.
NCT02051101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02051101 about?
NCT02051101 is a clinical study titled "Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples". The purpose of this study is to investigate the pathogenic mechanisms of Port Wine Stain, collect biopsy samples and blood samples to characterize exosomes and metabolites from Port Wine Stain.
What is the current status of trial NCT02051101?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2013-04-23. Estimated completion is 2019-01-11.
What interventions are being tested in trial NCT02051101?
The interventions under investigation include: Biopsy sample from Port Wine Stain Birthmark (OTHER).
Who is sponsoring clinical trial NCT02051101?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.